|
Epithelial tumours |
|
Malignant | Benign |
|
(i) Acinic cell carcinoma | (i) Pleomorphic adenoma (PA) |
(ii) Mucoepidermoid carcinoma (MEC) | (a) Metastasizing pleomorphic adenoma |
(iii) Adenoid cystic carcinoma (ACC) | (ii) Myoepithelioma |
(iv) Polymorphous adenocarcinoma (PAC) (before 2017: Polymorphous low-grade adenocarcinoma – PLGA) | (iii) Basal cell adenoma |
(v) Epithelial-myoepithelial carcinoma (EMC) | (iv) Warthin’s tumour |
(vi) Clear cell carcinoma | (v) Oncocytoma |
(vii) Basal cell adenocarcinoma | (vi) Canalicular adenoma |
(viii) Sebaceous carcinoma | (vii) Lymphadenoma |
(ix) Intraductal carcinoma | (a) Sebaceous lymphadenoma |
(a) Low-grade cribriform cystadenocarcinoma | (b) Nonsebaceous lymphadenoma |
(b) Salivary duct carcinoma | (c) Sebaceous lymph adenocarcinoma |
(c) Salivary duct carcinoma, not otherwise specified | (viii) Ductal papilloma |
(x) Oncocytic carcinoma | (a) Inverted ductal papilloma |
(xi) Adenocarcinoma, not otherwise specified (NOS) | (b) Intraductal papilloma |
(a) Cystadenocarcinoma | (c) Sialadenoma papilliferum |
(b) Mucinous adenocarcinoma | (ix) Cystadenoma |
(xii) Myoepithelial carcinoma | |
(xiii) Carcinoma ex pleomorphic adenoma (CXPA) | |
(xiv) Secretory carcinoma | |
(xv) Carcinosarcoma | |
(xvi) Squamous cell carcinoma | |
(xvii) Large cell carcinoma | |
(xviii) Lymphoepithelial carcinoma | |
(xix) Sialoblastoma | |
|
Other epithelial lesions |
|
(i) Intercalated duct lesions |
(a) Intercalated duct adenoma |
(b) Intercalated duct hyperplasia (IDH) |
(ii) Nodular oncocytic hyperplasia |
(iii) Lymphoepithelial lesions |
|
Soft tissue tumours |
|
(i) Haemangioma |
(ii) Lipoma |
(iii) Nodular fasciitis |
|
Haematolymphoid tumours |
|
(i) Hodgkin lymphoma |
(ii) Diffuse large B-cell lymphoma |
(iii) Extranodal marginal zone B-cell lymphoma |
|
Secondary tumours |
|
(i) Tumours which have metastasized to the salivary gland from another location |
|